| __timestamp | BeiGene, Ltd. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 4101058 |
| Thursday, January 1, 2015 | 58250000000 | 10763215 |
| Friday, January 1, 2016 | 98033000 | 5579049 |
| Sunday, January 1, 2017 | 269018000 | 32051299 |
| Monday, January 1, 2018 | 679005000 | 24482286 |
| Tuesday, January 1, 2019 | 927338000 | 43892589 |
| Wednesday, January 1, 2020 | 1294877000 | 44505000 |
| Friday, January 1, 2021 | 1459239000 | 79406000 |
| Saturday, January 1, 2022 | 1640508000 | 49283000 |
| Sunday, January 1, 2023 | 1778594000 | 17282730 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. BeiGene, Ltd. and Verona Pharma plc, two prominent players in the industry, have shown contrasting approaches over the past decade.
Since 2014, BeiGene has consistently increased its R&D expenses, peaking in 2015 with a staggering 5.8 billion USD. This represents a nearly 8,000% increase from its 2014 spending, underscoring its aggressive pursuit of groundbreaking therapies.
In contrast, Verona Pharma's R&D spending has grown more modestly, with a peak in 2021 at approximately 79 million USD. This reflects a more measured approach, focusing on targeted innovations.
These spending patterns highlight the diverse strategies within the biotech sector, where both aggressive and steady investments can lead to success.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and BeiGene, Ltd.
R&D Insights: How Novartis AG and BeiGene, Ltd. Allocate Funds
Comparing Innovation Spending: Gilead Sciences, Inc. and BeiGene, Ltd.
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Comparing Innovation Spending: BeiGene, Ltd. and Ultragenyx Pharmaceutical Inc.
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Viking Therapeutics, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Viridian Therapeutics, Inc.